Annual Debt To Equity
0.13
+0.04+44.44%
December 31, 2022
Summary
- As of February 10, 2025, NLTX annual debt to equity ratio is 0.13, with the most recent change of +0.04 (+44.44%) on December 31, 2022.
- During the last 3 years, NLTX annual debt to equity has risen by +0.12 (+1200.00%).
Performance
NLTX Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Debt To Equity
0.14
0.000.00%
September 30, 2023
Summary
- As of February 10, 2025, NLTX quarterly debt to equity ratio is 0.14, unchanged on September 30, 2023.
- Over the past year, NLTX quarterly debt to equity has increased by +0.03 (+27.27%).
Performance
NLTX Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Debt To Equity Formula
Debt To Equity = Total Debt
Shareholders Equity
Total Debt
Shareholders Equity
Shareholders Equity
NLTX Debt To Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +44.4% | +27.3% |
| 3 y3 years | +1200.0% | +133.3% |
| 5 y5 years | +100.0% | +100.0% |
NLTX Debt To Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -30.8% | at high | -35.7% |
| 5 y | 5-year | at high | -92.3% | at high | -92.9% |
| alltime | all time | at high | -123.1% | at high | -121.4% |
Neoleukin Therapeutics Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | 0.14(0.0%) |
| Jun 2023 | - | 0.14(0.0%) |
| Mar 2023 | - | 0.14(+7.7%) |
| Dec 2022 | 0.13(+44.4%) | 0.13(+18.2%) |
| Sep 2022 | - | 0.11(0.0%) |
| Jun 2022 | - | 0.11(+10.0%) |
| Mar 2022 | - | 0.10(+11.1%) |
| Dec 2021 | 0.09(+50.0%) | 0.09(0.0%) |
| Sep 2021 | - | 0.09(+12.5%) |
| Jun 2021 | - | 0.08(0.0%) |
| Mar 2021 | - | 0.08(+33.3%) |
| Dec 2020 | 0.06(+500.0%) | 0.06(0.0%) |
| Sep 2020 | - | 0.06(-25.0%) |
| Jun 2020 | - | 0.08(0.0%) |
| Mar 2020 | - | 0.08(+700.0%) |
| Dec 2019 | 0.01(>+9900.0%) | 0.01(0.0%) |
| Sep 2019 | - | 0.01(0.0%) |
| Jun 2019 | - | 0.01(0.0%) |
| Mar 2019 | - | 0.01(>+9900.0%) |
| Dec 2018 | 0.00 | 0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | 0.00(0.0%) |
| Jun 2018 | - | 0.00(0.0%) |
| Mar 2018 | - | 0.00(0.0%) |
| Dec 2017 | 0.00(0.0%) | 0.00(0.0%) |
| Sep 2017 | - | 0.00(0.0%) |
| Jun 2017 | - | 0.00(0.0%) |
| Mar 2017 | - | 0.00(0.0%) |
| Dec 2016 | 0.00(0.0%) | 0.00(0.0%) |
| Sep 2016 | - | 0.00(0.0%) |
| Jun 2016 | - | 0.00(0.0%) |
| Mar 2016 | - | 0.00(0.0%) |
| Dec 2015 | 0.00(0.0%) | 0.00(0.0%) |
| Sep 2015 | - | 0.00(0.0%) |
| Jun 2015 | - | 0.00(0.0%) |
| Mar 2015 | - | 0.00(0.0%) |
| Dec 2014 | 0.00(-100.0%) | 0.00(0.0%) |
| Sep 2014 | - | 0.00(0.0%) |
| Jun 2014 | - | 0.00(0.0%) |
| Mar 2014 | - | 0.00(-100.0%) |
| Dec 2013 | -0.03(<-9900.0%) | -0.03 |
| Dec 2012 | 0.00 | - |
FAQ
- What is Neoleukin Therapeutics annual debt to equity ratio?
- What is the all time high annual debt to equity for Neoleukin Therapeutics?
- What is Neoleukin Therapeutics annual debt to equity year-on-year change?
- What is Neoleukin Therapeutics quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for Neoleukin Therapeutics?
- What is Neoleukin Therapeutics quarterly debt to equity year-on-year change?
What is Neoleukin Therapeutics annual debt to equity ratio?
The current annual debt to equity of NLTX is 0.13
What is the all time high annual debt to equity for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high annual debt to equity ratio is 0.13
What is Neoleukin Therapeutics annual debt to equity year-on-year change?
Over the past year, NLTX annual debt to equity ratio has changed by +0.04 (+44.44%)
What is Neoleukin Therapeutics quarterly debt to equity ratio?
The current quarterly debt to equity of NLTX is 0.14
What is the all time high quarterly debt to equity for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high quarterly debt to equity ratio is 0.14
What is Neoleukin Therapeutics quarterly debt to equity year-on-year change?
Over the past year, NLTX quarterly debt to equity ratio has changed by +0.03 (+27.27%)